Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2007. Start Trial.
Date Value
October 09, 2026 0.6123
October 08, 2026 0.7912
October 07, 2026 1.105
October 06, 2026 1.292
October 05, 2026 1.566
October 02, 2026 2.974
October 01, 2026 1.455
September 30, 2026 1.030
September 29, 2026 1.300
September 28, 2026 0.6242
September 25, 2026 0.5924
September 24, 2026 0.5129
September 23, 2026 0.4453
September 22, 2026 0.5049
September 21, 2026 0.3976
September 18, 2026 0.4135
September 17, 2026 0.3345
September 16, 2026 0.3324
September 15, 2026 0.3413
September 14, 2026 0.3518
September 11, 2026 0.3551
September 10, 2026 0.3418
September 09, 2026 0.3484
September 08, 2026 0.3459
September 04, 2026 0.3539
Date Value
September 03, 2026 0.3541
September 02, 2026 0.3416
September 01, 2026 0.3418
August 31, 2026 0.3758
August 28, 2026 0.3716
August 27, 2026 0.3892
August 26, 2026 0.3857
August 25, 2026 0.4135
August 24, 2026 0.4453
August 21, 2026 0.4533
August 20, 2026 0.4453
August 19, 2026 0.3976
August 18, 2026 0.3696
August 17, 2026 0.3896
August 14, 2026 0.4095
August 13, 2026 0.3976
August 12, 2026 0.3976
August 11, 2026 0.4135
August 10, 2026 0.4055
August 07, 2026 0.4095
August 06, 2026 0.4135
August 05, 2026 0.4095
August 04, 2026 0.3817
August 03, 2026 0.4413
July 31, 2026 0.4572

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 2.842
Corcept Therapeutics, Inc. 18.53
Veru, Inc. 1.478
Johnson & Johnson 7.410
Eli Lilly & Co. 32.77

Price to Book Value Related Metrics

PS Ratio 14.77
Price 1.54
Earnings Yield -48.09%
Market Cap 77.91M